Correlation Between Inhibrx and Chemours
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Chemours at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Chemours into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Chemours Co, you can compare the effects of market volatilities on Inhibrx and Chemours and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Chemours. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Chemours.
Diversification Opportunities for Inhibrx and Chemours
Good diversification
The 3 months correlation between Inhibrx and Chemours is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Chemours Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chemours and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Chemours. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chemours has no effect on the direction of Inhibrx i.e., Inhibrx and Chemours go up and down completely randomly.
Pair Corralation between Inhibrx and Chemours
Given the investment horizon of 90 days Inhibrx is expected to generate 1.37 times more return on investment than Chemours. However, Inhibrx is 1.37 times more volatile than Chemours Co. It trades about 0.0 of its potential returns per unit of risk. Chemours Co is currently generating about 0.0 per unit of risk. If you would invest 2,925 in Inhibrx on September 3, 2024 and sell it today you would lose (1,399) from holding Inhibrx or give up 47.83% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Chemours Co
Performance |
| Timeline |
| Inhibrx |
| Chemours |
Inhibrx and Chemours Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Chemours
The main advantage of trading using opposite Inhibrx and Chemours positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Chemours can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will offset losses from the drop in Chemours' long position.| Inhibrx vs. DiaMedica Therapeutics | Inhibrx vs. Lyra Therapeutics | Inhibrx vs. Centessa Pharmaceuticals PLC |
| Chemours vs. SPACE | Chemours vs. Bayview Acquisition Corp | Chemours vs. T Rowe Price | Chemours vs. Ampleforth |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stocks Directory Find actively traded stocks across global markets |